MedDataX Logo

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

NCT ID: NCT00881231

Last Updated: 2017-03-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1

Total Enrollment

26 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-01-31

Study Completion Date

2004-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Celecoxib Japan Observational Study for the Patients With Acute Pain

NCT01876121

Patients With Traumatic Pain, Post-surgical Pain and Tooth Extract Pain
COMPLETED

Comparison of Bioavailability of Dexketoprofen-Vit B vs Dexketoprofen, in Healthy Subjects, Under Fasting Conditions

NCT05027126

Healthy
COMPLETED PHASE1

A Comparison of NSAIDs for Acute, Non-radicular Low Back Pain.

NCT03861611

Back Pain Without Radiation Low Back Pain
COMPLETED PHASE4

Efficacy and Safety Study of NPC-01 to Treat Dysmenorrhea

NCT01129102

Dysmenorrhea
COMPLETED PHASE3

Pharmacokinetics of 3 Formulations of Ibuprofen Suppositories

NCT00921830

Healthy
COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Cilostazol 50 mg Tablets (Eon Pharma, LLC, USA)

Group Type EXPERIMENTAL

Cilostazol 50 mg Tablets (Eon Pharma, LLC, USA)

Intervention Type DRUG

2

Pletal (Cilostazol) 50 mg Tablets (Otsuka Pharma Co, Ltd., USA)

Group Type ACTIVE_COMPARATOR

Pletal (Cilostazol) 50 mg Tablets (Otsuka Pharma Co, Ltd., USA)

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cilostazol 50 mg Tablets (Eon Pharma, LLC, USA)

Intervention Type DRUG

Pletal (Cilostazol) 50 mg Tablets (Otsuka Pharma Co, Ltd., USA)

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening.

Exclusion Criteria

* Positive test results for HIV or hepatitis B or C.
* Treatment for drug or alcohol dependence.
Minimum Eligible Age

19 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sandoz

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sandoz Inc.

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gaetano Morelli, M.D.

Role: PRINCIPAL_INVESTIGATOR

MDS Pharma Services

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AA17524

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Bioequivalency Study of Ibuprofen 200 mg and Pseudoephedrine HCL 30 mg Tablets of Dr. Reddy's Under Fasting Conditions
NCT01131780 COMPLETED PHASE1
Study to Investigate the Relative Bioavailability of Ibuprofen in Healthy Volunteers
NCT02183012 COMPLETED PHASE1
RCT, Blinded, 2-Arm Efficacy Study of IP and Placebo in Patients With Chronic Pain Related to Osteoarthritis of the Knee
NCT05318521 UNKNOWN PHASE3
A Study to Investigate the Efficacy of Pain Bloc-R in Healthy Participants With Non-pathological Aches and Discomfort
NCT03965819 COMPLETED NA
Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fasting Conditions
NCT00804440 COMPLETED PHASE1
Ibuprofen-PC Compared With Ibuprofen in a GI Safety Trial
NCT00219700 COMPLETED PHASE2
Celebrex Premedication in Teeth With Symptomatic Irreversible Pulpitis
NCT03339544 UNKNOWN NA
Effectiveness of PEA Compared to Placebo on Acute Menstrual Pain
NCT05810116 COMPLETED PHASE4
A Study Comparing the Efficacy and Safety of Orally Administered Ibuprofen and Placebo in Delayed Onset Muscle Soreness
NCT02113566 COMPLETED PHASE4
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study Of PF-04427429 In Healthy Women Volunteers
NCT01511497 COMPLETED PHASE1
A Randomized Trial of NSAID Dosing Strategies
NCT05239767 COMPLETED PHASE4
Efficacy and Safety Study of Ibuprofen Gel Compared to Placebo in the Treatment of Acute Musculoskeletal Pain
NCT05013567 UNKNOWN PHASE3
Study of Non Inferiority Bi-Profenid® 200mg Versus Bi-Profenid® 300mg Among Patients Presenting of the Post-traumatic or Rheumatologic Acute Affections of the Locomotor Apparatus (BIPROPAIN)
NCT00810121 COMPLETED PHASE3
Pilot Mouthwash Study of Pioglitazone and Simvastatin in Healthy Volunteers
NCT00531882 COMPLETED NA
Assessment of the Analgesic Effects of PF-06273340 in Healthy Volunteers Using Evoked Pain Endpoints
NCT02260947 COMPLETED PHASE1
A Study to Test Bioequivalence Between One Test Formulation of Ibuprofen and Two Reference Treatments
NCT01316978 COMPLETED PHASE1
Bioequivalence Study of Dr.Reddy's Ibuprofen and Diphenhydramine Citrate 200 mg/38 mg Caplets Under Fasting Condition
NCT01053208 COMPLETED PHASE1
Open-Label, Placebo-Controlled, Parallel Group Study in Healthy Volunteers to Evaluate the Effects of Two Single MT 400 or Naproxen Sodium Tablets
NCT00596245 COMPLETED PHASE1
A Safety Trial to Compare Different Analgesics in Combination With Low Dose Aspirin to Study Their Bleeding Properties and Their Effects on the Stomach
NCT00261586 COMPLETED PHASE4
Tolerability and Efficacy of Ibuprofen 800 mg in a Walking Model of Osteoarthritis Pain (0000-057)
NCT00565084 COMPLETED PHASE1
Single-Dose Bioavailability Study of Two Formulations of Ibuprofen and Pseudoephedrine Hydrochloride Tablets
NCT03429738 COMPLETED PHASE1
A Study Comparing Three Formulations of Ibuprofen in Healthy Subjects
NCT02256423 COMPLETED PHASE1
Acute Low Back Pain. Topical Diclofenac and Oral Ibuprofen.
NCT04611529 COMPLETED PHASE4
Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fed Conditions
NCT00803946 COMPLETED PHASE1
Tolerability, Safety and Activity of a Muscle Relaxant Molecule IDN5243 in Patients With Low Back Pain
NCT02568826 WITHDRAWN PHASE2